CVS Health (CVS) said Friday that data from its weight management program showed participants lost an average of 15% of their weight.
The data was derived from 265,000 patients participating in the program. They included those using GLP-1 anti-obesity medications, who nearly doubled their pre-program weight loss while working with the program to change their diet and lifestyle, the company said.
"The data are clear: GLP-1 weight-loss drugs work best when combined with nutrition, lifestyle support and proper dosing2," said Michelle Gourdine, chief medical officer at CVS Caremark.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。